Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Preclinical
Sponsor : Circio
Deal Size : Undisclosed
Deal Type : Collaboration
Circio, NeoRegen Biotech to Advance Circular RNA Delivery Collaboration
Details : The collaboration between Circio Holding ASA and NeoRegen Biotech is focused on advancing circular RNA (circRNA) expression-based therapeutics toward clinical readiness.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
June 30, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Preclinical
Sponsor : Circio
Deal Size : Undisclosed
Deal Type : Collaboration